UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorQualiMed Innovative Medizinprodukte GmbH

About this trial

STUDY TYPE: Feasibility study STUDY DESIGN: Prospective, multicenter, single-arm, open-label PRIMARY OBJECTIVE The primary objective is to assess safety of the UNITY Balloon-expandable Biodegradable Biliary Stent System SECONDARY OBJECTIVES Clinical /Technical /Procedural success, Quality of Life improvement, biodegradation rate

Eligibility criteria

Qualifiers

Benign fibrotic distal bile duct obstruction

Duct occlusion caused by cholelithiasis

A benign fibrotic distal obstruction of the Common Bile Duct (CBD), demonstrated by presence of a stenosis on magnetic resonance cholangiopancreatography (MRCP) and/or ERCP with proximal ductal dilation and cholestatic liver enzymes levels

Ductal anastomotic strictures

Disqualifiers

Subject is unwilling to comply with the follow-up schedule

Life expectancy < 12 m,

Inability to pass a guidewire through stricture

Contra-indication for endoscopy or interventional radiology

Trial design

Treatments tested in this trial

  • Biliary Duct Stenting

Treatment groups

100 Participants
are divided into 1 treatment group